$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Lorlatinib is a first-generation targeted drug
2026-02-01 22:25:32
Check Details
Lorlatinib manufacturer and manufacturer
2026-02-01 22:25:32
Check Details
The latest instructions for lorlatinib in 2024, patients must read before taking the drug!
2026-02-01 22:25:32
Check Details
What are the side effects of lorlatinib?
2026-02-01 22:25:32
Check Details
The efficacy and role of lorlatinib, a must-read for patients!
2026-02-01 22:25:32
Check Details
What is the average duration of resistance to lorlatinib?
2026-02-01 22:25:32
Check Details
How much does a box of genuine lorlatinib cost?
2026-02-01 22:25:32
Check Details
Lorlatinib for the treatment of lung cancer
2026-02-01 22:25:32
Check Details
Lorlatinib Medicare Price 2024
2026-02-01 22:25:32
Check Details
Lorlatinib Chemical Properties
2026-02-01 22:25:32
Check Details
How to use Lorlatinib
2026-02-01 22:25:32
Check Details
Lorlatinib usage and dosage
2026-02-01 22:25:32
Check Details
1
2
...
409
410
411
412
413
414
415
...
10210
10211
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
2
Opicapone Contraindications: Essential Restrictions for At-Risk Groups
3
Finerenone: An Innovative Treatment for Diabetic Kidney Disease
4
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
5
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
6
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
7
Sirolimus (Rapamune) Comprehensive Clinical Guide
8
Lusutrombopag Efficacy, Dosage and Storage Instructions
9
Icotyde (Icotrokinra) Side Effects, Pharmacokinetics and Storage Instructions
10
Cemiplimab (Libtayo) Drug Information
11
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma
12
Urece (Dotinurad): Highly Selective URAT1 Inhibitor for Gout and Hyperuricemia